Semin Neurol 2023; 43(03): 370-387
DOI: 10.1055/s-0043-1771208
Review Article

Surgery for Malignant Acute Ischemic Stroke: A Narrative Review of the Knowns and Unknowns

Kailash Krishnan*
1   Stroke Unit, Department of Acute Medicine Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2   Stroke Trials Unit, University of Nottingham, Nottingham, United Kingdom
,
Milo Hollingworth*
3   Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
Thanh N. Nguyen
4   Department of Neurology, Neurosurgery and Radiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts
,
Ashwin Kumaria
3   Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
Matthew A. Kirkman
3   Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
Surajit Basu
3   Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
Christos Tolias
5   Department of Neurosurgery, King's College Hospitals NHS Foundation Trust, London, United Kingdom
,
Philip M. Bath
1   Stroke Unit, Department of Acute Medicine Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2   Stroke Trials Unit, University of Nottingham, Nottingham, United Kingdom
,
Nikola Sprigg
1   Stroke Unit, Department of Acute Medicine Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2   Stroke Trials Unit, University of Nottingham, Nottingham, United Kingdom
› Author Affiliations

Abstract

Malignant acute ischemic stroke (AIS) is characterized by acute neurological deterioration caused by progressive space-occupying brain edema, often occurring in the first hours to days after symptom onset. Without any treatment, the result is often fatal. Despite advances in treatment for AIS, up to 80% of patients with a large hemispheric stroke or cerebellar stroke are at risk of poor outcome. Decompressive surgery can be life-saving in a subgroup of patients with malignant AIS, but uncertainties exist on patient selection, predictors of malignant infarction, perioperative management, and timing of intervention. Although survivors are left disabled, most agree with the original decision to undergo surgery and would make the same decision again. In this narrative review, we focus on the clinical and radiological predictors of malignant infarction in AIS and outline the technical aspects of decompressive surgery as well as duraplasty and cranioplasty. We discuss the current evidence and recommendations for surgery in AIS, highlighting gaps in knowledge, and suggest directions for future studies.

Key Points

  • Acute ischemic stroke from occlusion of a proximal intracranial artery can progress quickly to malignant edema, which can be fatal in 80% of patients despite medical management.

  • Decompression surgery is life-saving within 48 hours of stroke onset, but the benefits beyond this time and in the elderly are unknown.

  • Decompressive surgery is associated with high morbidity, particularly in the elderly. The decision to operate must be made after considering the individual's preference and expectations of quality of life in the context of the clinical condition.

  • Further studies are needed to refine surgical technique including value of duraplasty and understand the role monitoring intracranial pressure during and after decompressive surgery.

  • More studies are needed on the pathophysiology of malignant cerebral edema, prediction models including imaging and biomarkers to identify which subgroup of patients will benefit from decompressive surgery.

  • More research is needed on factors associated with morbidity and mortality after cranioplasty, safety and efficacy of implants, and comparisons between them.

  • Further studies are needed to assess the long-term effects of physical disability and quality of life of survivors after surgery, particularly those with severe neurological deficits.

* Authors contributed equally to this manuscript.




Publication History

Article published online:
18 August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Feigin VL, Stark BA, Johnson CO. et al; GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20 (10) 795-820
  • 2 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53 (04) 309-315
  • 3 Emberson J, Lees KR, Lyden P. et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384 (9958) 1929-1935
  • 4 Goyal M, Menon BK, van Zwam WH. et al; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387 (10029): 1723-1731
  • 5 Jovin TG, Li C, Wu L. et al; BAOCHE Investigators. Trial of thrombectomy 6 to 24.  hours after stroke due to basilar-artery occlusion. N Engl J Med 2022; 387 (15) 1373-1384
  • 6 Tao C, Nogueira RG, Zhu Y. et al; ATTENTION Investigators. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 2022; 387 (15) 1361-1372
  • 7 Bhatia R, Hill MD, Shobha N. et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010; 41 (10) 2254-2258
  • 8 Seker F, Qureshi MM, Möhlenbruch MA. et al. Reperfusion without functional independence in late presentation of stroke with large vessel occlusion. Stroke 2022; 53 (12) 3594-3604
  • 9 Nguyen TN, Qureshi MM, Klein P. et al; SVIN COVID-19 Global Stroke Registry. Global impact of the COVID-19 pandemic on stroke volumes and cerebrovascular events: a 1-year follow up. Neurology 2023; 100 (04) e408-e421
  • 10 Alexander P, Heels-Ansdell D, Siemieniuk R. et al. Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis. BMJ Open 2016; 6 (11) e014390
  • 11 Murthy JM. Outcome following decompressive hemicraniectomy in malignant middle cerebral artery infarct: does age matters?. Neurol India 2012; 60 (06) 565-566
  • 12 Torbey MT, Bösel J, Rhoney DH. et al. Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine. Neurocrit Care 2015; 22 (01) 146-164
  • 13 Kolias AG, Kirkpatrick PJ, Hutchinson PJ. Decompressive craniectomy: past, present and future. Nat Rev Neurol 2013; 9 (07) 405-415
  • 14 Beez T, Munoz-Bendix C, Steiger HJ, Beseoglu K. Decompressive craniectomy for acute ischemic stroke. Crit Care 2019; 23 (01) 209
  • 15 Neugebauer H, Witsch J, Zweckberger K, Jüttler E. Space-occupying cerebellar infarction: complications, treatment, and outcome. Neurosurg Focus 2013; 34 (05) E8
  • 16 Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med 1986; 314 (15) 953-958
  • 17 Wijdicks EF, Sheth KN, Carter BS. et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for health professionals from the American Heart Association. Stroke 2014; 45: 1222-1238
  • 18 Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999; 30 (02) 287-292
  • 19 Jaramillo A, Góngora-Rivera F, Labreuche J, Hauw JJ, Amarenco P. Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology 2006; 66 (06) 815-820
  • 20 Kasner SE, Demchuk AM, Berrouschot J. et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001; 32 (09) 2117-2123
  • 21 Williams JL, Furlan AJ. Cerebral vascular physiology in hypertensive disease. Neurosurg Clin N Am 1992; 3 (03) 509-520
  • 22 Miao J, Song X, Sun W, Qiu X, Lan Y, Zhu Z. Predictors of malignant cerebral edema in cerebral artery infarction: a meta-analysis. J Neurol Sci 2020; 409: 116607
  • 23 Flores A, Rubiera M, Ribó M. et al. Poor collateral circulation assessed by multiphase computed tomographic angiography predicts malignant cerebral artery evolution after reperfusion therapies. Stroke 2015; 46 (11) 3149-3153
  • 24 Ryoo JW, Na DG, Kim SS. et al. Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr 2004; 28 (01) 55-62
  • 25 Reinhard M, Rutsch S, Lambeck J. et al. Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke. Acta Neurol Scand 2012; 125 (03) 156-162
  • 26 Kucinski T, Koch C, Grzyska U, Freitag HJ, Krömer H, Zeumer H. The predictive value of early CT and angiography for fatal hemispheric swelling in acute stroke. AJNR Am J Neuroradiol 1998; 19 (05) 839-846
  • 27 Jo K, Bajgur SS, Kim H, Choi HA, Huh PW, Lee K. A simple prediction score system for malignant brain edema progression in large hemispheric infarction. PLoS One 2017; 12 (02) e0171425
  • 28 Oppenheim C, Samson Y, Manaï R. et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000; 31 (09) 2175-2181
  • 29 Thomalla GJ, Kucinski T, Schoder V. et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003; 34 (08) 1892-1899
  • 30 Lee CL, Kandasamy R, Mohammad Raffiq MAB. Computed tomography perfusion in detecting malignant middle cerebral artery infarct. Surg Neurol Int 2019; 10 (159) 159
  • 31 Lin J, Frontera JA. Decompressive hemicraniectomy for large hemispheric strokes. Stroke 2021; 52 (04) 1500-1510
  • 32 Bektas H, Wu T-C, Kasam M. et al. Increased blood-brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction. Stroke 2010; 41 (11) 2539-2544
  • 33 Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998; 29 (12) 2556-2562
  • 34 Dohmen C, Bosche B, Graf R. et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003; 34 (09) 2152-2158
  • 35 Dubourg J, Javouhey E, Geeraerts T, Messerer M, Kassai B. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med 2011; 37 (07) 1059-1068
  • 36 Güzeldağ S, Yılmaz G, Tuna M, Altuntaş M, Özdemir M. Measuring the optic nerve sheath diameter with ultrasound in acute middle cerebral artery stroke patients. J Stroke Cerebrovasc Dis 2021; 30 (02) 105523
  • 37 Lochner P, Fassbender K, Andrejewski A. et al. Sonography of optic nerve sheath diameter identifies patients with middle cerebral artery infarction at risk of a malignant course: a pilot prospective observational study. J Neurol 2020; 267 (09) 2713-2720
  • 38 Perez-Nellar J, Scherle C, Machado C. TCD systolic spikes in a malignant MCA infarct. Neurocrit Care 2009; 11 (01) 94-96
  • 39 Wang Q, Ye H, Su Y. Transcranial Doppler sonography monitors cerebral blood flow of mannitol-treated patients with acute large hemispheric infarction. Turk Neurosurg 2014; 24 (03) 333-336
  • 40 MacCallum C, Churilov L, Mitchell P, Dowling R, Yan B. Low Alberta Stroke Program Early CT score (ASPECTS) associated with malignant middle cerebral artery infarction. Cerebrovasc Dis 2014; 38 (01) 39-45
  • 41 Ong CJ, Gluckstein J, Laurido-Soto O, Yan Y, Dhar R, Lee JM. Enhanced detection of oedema in malignant anterior circulation stroke (EDEMA) score: a risk prediction tool. Stroke 2017; 48 (07) 1969-1972
  • 42 Bechstein M, Meyer L, Breuel S. et al. Computed tomography based score of early ischemic changes predicts malignant infarction. Front Neurol 2021; 12 (669828): 669828
  • 43 Huang X, Chen C, Wang H. et al. The ACORNS grading scale: a novel tool for the prediction of malignant brain edema after endovascular thrombectomy. J Neurointerv Surg 2022; DOI: 10.1136/jnis-2022-019404.
  • 44 Shimoyama T, Kimura K, Uemura J. et al. The DASH score: a simple score to assess risk for development of malignant middle cerebral artery infarction. J Neurol Sci 2014; 338 (1-2): 102-106
  • 45 Dagonnier M, Donnan GA, Davis SM, Dewey HM, Howells DW. Acute stroke biomarkers: are we there yet?. Front Neurol 2021; 12 (619721): 619721
  • 46 Wu S, Yuan R, Wang Y. et al. Early prediction of malignant brain oedema after ischaemic stroke. Stroke 2018; 49 (12) 2918-2927
  • 47 Zhang Y, Liu G, Wang Y, Su Y, Leak RK, Cao G. Procalcitonin as a biomarker for malignant cerebral edema in massive cerebral infarction. Sci Rep 2018; 8 (01) 993
  • 48 Ibrahim F, Menezes S, Buhnerkempe M, Fifer A, Meyer K, Allam H. Systemic white blood cell count as a biomarker for malignant cerebral edema in large vessel ischemic MCA stroke. J Stroke Cerebrovasc Dis 2022; 31 (08) 106550
  • 49 Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers Med 2009; 3 (04) 363-383
  • 50 Foerch C, Otto B, Singer OC. et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 2004; 35 (09) 2160-2164
  • 51 Wang L, Deng L, Yuan R, Liu J, Li Y, Liu M. Association of matrix metalloproteinase 9 and cellular fibronectin and outcome in acute ischemic stroke: a systematic review and meta-analysis. Front Neurol 2020; 11: 523506
  • 52 Serena J, Blanco M, Castellanos M. et al. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke 2005; 36 (09) 1921-1926
  • 53 McAdoo DJ, Wu P. Microdialysis in central nervous system disorders and their treatment. Pharmacol Biochem Behav 2008; 90 (02) 282-296
  • 54 Bosche B, Dohmen C, Graf R. et al. Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke 2003; 34 (12) 2908-2913
  • 55 Timofeev I, Santarius T, Kolias AG, Hutchinson PJ. Decompressive craniectomy - operative technique and perioperative care. Adv Tech Stand Neurosurg 2012; 38: 115-136
  • 56 Zweckberger K, Juettler E, Bösel J, Unterberg WA. Surgical aspects of decompression craniectomy in malignant stroke: review. [ review] Cerebrovasc Dis 2014; 38 (05) 313-323
  • 57 Akins PT, Guppy KH. Sinking skin flaps, paradoxical herniation, and external brain tamponade: a review of decompressive craniectomy management. Neurocrit Care 2008; 9 (02) 269-276
  • 58 Sarov M, Guichard J-P, Chibarro S. et al; DECIMAL Investigators. Sinking skin flap syndrome and paradoxical herniation after hemicraniectomy for malignant hemispheric infarction. Stroke 2010; 41 (03) 560-562
  • 59 Das S, Mitchell P, Ross N, Whitfield PC. Decompressive hemicraniectomy in the treatment of malignant middle cerebral artery infarction: a meta-analysis. World Neurosurg 2019; 123: 8-16
  • 60 Jüttler E, Unterberg A, Woitzik J. et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 2014; 370 (12) 1091-1100
  • 61 Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB. HAMLET Investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009; 8 (04) 326-333
  • 62 Frank JI, Schumm LP, Wroblewski K. et al; HeADDFIRST Trialists. Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke 2014; 45 (03) 781-787
  • 63 Zhao J, Su YY, Zhang Y. et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care 2012; 17 (02) 161-171
  • 64 Reinink H, Jüttler E, Hacke W. et al. Surgical decompression for space-occupying hemispheric infarction: a systematic review and individual patient meta-analysis of randomised clinical trials. JAMA Neurol 2021; 78 (02) 208-216
  • 65 Jüttler E, Schwab S, Schmiedek P. et al; DESTINY Study Group. Decompressive surgery for the treatment of malignant infarction of the Middle Cerebral Artery (DESTINY). Stroke 2007; 38 (09) 2518-2525
  • 66 Chua AE, Buckley BS, Lapitan MCM. et al. Hemicraniectomy for malignant middle cerebral artery infarction (HeMMI): a randomised controlled clinical trial of decompressive hemicraniectomy with standardised medical care versus standard medical care alone. Acta Med Philipp 2015; 49 (01) 28-33
  • 67 Vahedi K, Vicaut E, Mateo J. et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007; 38 (09) 2506-2517
  • 68 Vahedi K, Hofmeijer J, Juettler E. et al; DECIMAL, DESTINY, and HAMLET Investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6 (03) 215-222
  • 69 Slezins J, Keris V, Bricis R. et al. Preliminary results of randomized controlled study on decompressive craniectomy in treatment of malignant middle cerebral artery stroke. Medicina (Kaunas) 2012; 48 (10) 521-524
  • 70 Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 2004; 35 (02) 539-543
  • 71 Back L, Nagaraja V, Kapur A, Eslick GD. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a meta-analysis of randomised trials. Intern Med J 2015; 45 (07) 711-717
  • 72 Borger V, Schuss P, Kinfe TM, Vatter H, Güresir E. Decompressive craniectomy for stroke: early cranioplasty is a predictor for postoperative complications. World Neurosurg 2016; 92: 83-88
  • 73 Staykov D, Schwab S. Should age be considered when proposing decompressive hemicraniectomy in malignant stroke, and if so where is the limit?. Neurocrit Care 2012; 17 (02) 159-160
  • 74 Rahme R, Zuccarello M, Kleindorfer D, Adeoye OM, Ringer AJ. Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction: is life worth living?. J Neurosurg 2012; 117 (04) 749-754
  • 75 van Middelaar T, Richard E, van der Worp HB. et al. Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: a cohort study. BMC Neurol 2015; 15: 156
  • 76 Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol 2013; 12 (10) 989-998
  • 77 Nouh A, Remke J, Ruland S. Ischaemic posterior circulation stroke: a review of anatomy, clinical presentation, diagnosis and current management. Front Neurol 2014; 5 (30) 1-16
  • 78 Wardlaw JM, Farrall AJ, Perry D. et al; Acute Cerebral CT Evaluation of Stroke Study (ACCESS) Study Group. Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke 2007; 38 (04) 1250-1256
  • 79 Fabritius MP, Reidler P, Froelich MF. et al. Incremental value of computed tomography perfusion for final infarct prediction in acute ischaemic cerebellar stroke. J Am Heart Assoc 2019; 8 (21) e013069
  • 80 Holly LT, Batzdorf U. Management of cerebellar ptosis following craniovertebral decompression for Chiari I malformation. J Neurosurg 2001; 94 (01) 21-26
  • 81 Ayling OGS, Alotaibi NM, Wang JZ. et al. Suboccipital decompressive craniectomy for cerebellar infarction: a systematic review and meta-analysis. World Neurosurg 2018; 110: 450-459.e5
  • 82 Jauss M, Krieger D, Hornig C, Schramm J, Busse O. Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study. J Neurol 1999; 246 (04) 257-264
  • 83 Kim MJ, Park SK, Song J. et al. Preventive suboccipital decompressive craniectomy for cerebellar infarction: a retrospective-matched case–control Study. Stroke 2016; 47 (10) 2565-2573
  • 84 Kastrau F, Wolter M, Huber W, Block F. Recovery from aphasia after hemicraniectomy for infarction of the speech-dominant hemisphere. Stroke 2005; 36 (04) 825-829
  • 85 Naeser MA, Gaddie A, Palumbo CL, Stiassny-Eder D. Late recovery of auditory comprehension in global aphasia. Improved recovery observed with subcortical temporal isthmus lesion vs Wernicke's cortical area lesion. Arch Neurol 1990; 47 (04) 425-432
  • 86 Woertgen C, Erban P, Rothoerl RD, Bein T, Horn M, Brawanski A. Quality of life after decompressive craniectomy in patients suffering from supratentorial brain ischemia. Acta Neurochir (Wien) 2004; 146 (07) 691-695
  • 87 Hofmeijer J, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, van Zandvoort MJ. Cognitive outcome of survivors of space-occupying hemispheric infarction. J Neurol 2013; 260 (05) 1396-1403
  • 88 Dasenbrock HH, Robertson FC, Vaitkevicius H. et al. Timing of decompressive hemicraniectomy for stroke: a nationwide inpatient sample analysis. Stroke 2017; 48 (03) 704-711
  • 89 Vibbert M, Mayer SA. Early decompressive hemicraniectomy following malignant ischemic stroke: the crucial role of timing. Curr Neurol Neurosci Rep 2010; 10 (01) 1-3
  • 90 Qureshi AI, Suarez JI, Yahia AM. et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicentre review. Crit Care Med 2003; 31: 277
  • 91 Elsawaf A, Galhom A. Decompressive craniotomy for malignant middle cerebral artery infarction: optimal timing and literature review. World Neurosurg 2018; 116: e71-e78
  • 92 Forsting M, Reith W, Schäbitz WR. et al. Decompressive craniectomy for cerebral infarction. An experimental study in rats. Stroke 1995; 26 (02) 259-264
  • 93 Landreneau MM, Sheth KN. Decompressive craniectomy for malignant middle cerebral artery stroke. Semin Respir Crit Care Med 2017; 38 (06) 737-744
  • 94 Kürten S, Munoz C, Beseoglu K, Fischer I, Perrin J, Steiger HJ. Decompressive hemicraniectomy for malignant middle cerebral artery infarction including patients with additional involvement of the anterior and/or posterior cerebral artery territory-outcome analysis and definition of prognostic factors. Acta Neurochir (Wien) 2018; 160 (01) 83-89
  • 95 Poca MA, Benejam B, Sahuquillo J. et al. Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful?. J Neurosurg 2010; 112 (03) 648-657
  • 96 Hofmeijer J, van der Worp HB, Kappelle LJ, Eshuis S, Algra A, Greving JP. HAMLET Steering Committee. Cost-effectiveness of surgical decompression for space-occupying hemispheric infarction. Stroke 2013; 44 (10) 2923-2925
  • 97 Bhattacharyya A, Tahir A, Chandrashekar A, Vasisht S, Stinson L, Omatseye J. A cost-utility analysis of decompressive hemicraniectomy versus medical treatment in the management of space-occupying brain oedema post middle cerebral artery infarction. Eur J Neurol 2019; 26 (02) 313-e19
  • 98 Powers WJ, Rabinstein AA, Ackerson T. et al; American Heart Association Stroke Council. Guidelines for the early management of patients with acute ischaemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49 (03) e46-e110
  • 99 van der Worp HB, Hofmeijer J, Juttler E. et al. European Stroke Organisation guidelines on the management of space-occupying brain infarction. Eur Stroke J 2021; 6 (02) XC-CX
  • 100 Chun HJ, Yi HJ. Efficacy and safety of early cranioplasty, at least within 1 month. J Craniofac Surg 2011; 22 (01) 203-207
  • 101 De Bonis P, Frassanito P, Mangiola A, Nucci CG, Anile C, Pompucci A. Cranial repair: how complicated is filling a “hole”?. J Neurotrauma 2012; 29 (06) 1071-1076
  • 102 Gooch MR, Gin GE, Kenning TJ, German JW. Complications of cranioplasty following decompressive craniectomy: analysis of 62 cases. Neurosurg Focus 2009; 26 (06) E9
  • 103 Fountain DM, Henry J, Honeyman S. et al; UK Cranial Reconstruction Registry (UKCRR) Collaborative, British Neurosurgical Trainee Research Collaborative (BNTRC). First report of a multicenter prospective registry of cranioplasty in the United Kingdom and Ireland. Neurosurgery 2021; 89 (03) 518-526
  • 104 Walcott BP, Kwon C-S, Sheth SA. et al. Predictors of cranioplasty complications in stroke and trauma patients. J Neurosurg 2013; 118 (04) 757-762
  • 105 Piedra MP, Ragel BT, Dogan A, Coppa ND, Delashaw JB. Timing of cranioplasty after decompressive craniectomy for ischemic or hemorrhagic stroke. J Neurosurg 2013; 118 (01) 109-114
  • 106 Xu H, Niu C, Fu X. et al. Early cranioplasty vs. late cranioplasty for the treatment of cranial defect: a systematic review. Clin Neurol Neurosurg 2015; 136: 33-40
  • 107 Schuss P, Vatter H, Marquardt G. et al. Cranioplasty after decompressive craniectomy: the effect of timing on postoperative complications. J Neurotrauma 2012; 29 (06) 1090-1095
  • 108 Beez T, Steiger H-J. Impact of randomized controlled trials on neurosurgical practice in decompressive craniectomy for ischemic stroke. Neurosurg Rev 2019; 42 (01) 133-137